Recent News

• 09.16.2025 - PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀
• 09.16.2025 - PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀
• 09.03.2025 - PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
• 09.03.2025 - PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
• 09.02.2025 - PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference
• 09.02.2025 - PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference
• 08.13.2025 - PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results
• 08.13.2025 - PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results
• 08.12.2025 - Yitzchak Jacobovitz - BOD
• 08.12.2025 - Yitzchak Jacobovitz - BOD

Recent Filings

• 09.16.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 09.16.2025 - EX-99.1 EX-99.1
• 09.08.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors